Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total Bond Market
BND
|
+$1.02B |
| 2 |
Canadian Natural Resources
CNQ
|
+$958M |
| 3 |
iShares Core US Aggregate Bond ETF
AGG
|
+$896M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$861M |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$756M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.62B |
| 2 |
Amgen
AMGN
|
+$1.68B |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$1.18B |
| 4 |
Visa
V
|
+$1.05B |
| 5 |
Invesco QQQ Trust
QQQ
|
+$1B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.79% |
| 2 | Healthcare | 9.32% |
| 3 | Financials | 8.97% |
| 4 | Consumer Discretionary | 7.33% |
| 5 | Industrials | 5.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZVSA
5351
DELISTED
ZyVersa Therapeutics
ZVSA
| $101K | ﹤0.01% |
+184
| New | +$537K |
|
5352
NextNav
NN
$2.02B
| $99.9K | ﹤0.01% |
34,107
+21,074
| +162% | +$64.8K |
|
5353
Sensus Healthcare
SRTS
$48.4M
| $99.8K | ﹤0.01% |
+13,454
| New | +$121K |
|
5354
Duluth Holdings
DLTH
$157M
| $99.7K | ﹤0.01% |
16,130
-1,373
| -8% | -$10.3K |
|
|
GAU
5355
Galiano Gold
GAU
$504M
| $99.6K | ﹤0.01% |
+191,627
| New | +$101K |
|
|
THRN
5356
DELISTED
Thorne Healthtech, Inc. Common Stock
THRN
| $98.9K | ﹤0.01% |
27,241
+1,459
| +6% | +$6.47K |
|
5357
Precision BioSciences
DTIL
$193M
| $98.1K | ﹤0.01% |
2,749
-3,203
| -54% | -$127K |
|
|
UBFO
5358
DELISTED
United Security Bancshares
UBFO
| $97.9K | ﹤0.01% |
13,397
-13,126
| -49% | -$91.3K |
|
5359
Invivyd
IVVD
$178M
| $97K | ﹤0.01% |
64,682
-75,782
| -54% | -$211K |
|
5360
Skillsoft
SKIL
$75.4M
| $96.2K | ﹤0.01% |
3,700
+837
| +29% | +$27.9K |
|
5361
Prelude Therapeutics
PRLD
$362M
| $95.2K | ﹤0.01% |
15,764
-5,971
| -27% | -$38.3K |
|
|
LENZ
5362
LENZ Therapeutics
LENZ
$165M
| $95K | ﹤0.01% |
4,086
-31,876
| -89% | -$739K |
|
5363
Capricor Therapeutics
CAPR
$228M
| $94.9K | ﹤0.01% |
24,594
-370
| -1% | -$1.77K |
|
|
ICVX
5364
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $94.9K | ﹤0.01% |
11,949
-27,607
| -70% | -$118K |
|
5365
Vera Bradley
VRA
$99.2M
| $94.5K | ﹤0.01% |
20,863
-4,377
| -17% | -$16K |
|
5366
Heritage Insurance Holdings
HRTG
$915M
| $94.4K | ﹤0.01% |
52,462
-12,881
| -20% | -$21.2K |
|
|
OMGA
5367
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $94.2K | ﹤0.01% |
16,506
-1,274
| -7% | -$7.15K |
|
|
KNDI
5368
Kandi Technologies Group
KNDI
$69.8M
| $93.6K | ﹤0.01% |
40,701
+26,972
| +196% | +$70.7K |
|
5369
StealthGas
GASS
$318M
| $92.9K | ﹤0.01% |
34,668
-255
| -0.7% | -$764 |
|
5370
Root
ROOT
$954M
| $92.2K | ﹤0.01% |
+20,536
| New | +$142K |
|
|
BBIG
5371
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
| $92.2K | ﹤0.01% |
9,932
+1,337
| +16% | +$20.6K |
|
|
VLD
5372
DELISTED
Velo3D, Inc.
VLD
| $91.8K | ﹤0.01% |
1,465
-895
| -38% | -$87K |
|
5373
Acumen Pharmaceuticals
ABOS
$162M
| $91.8K | ﹤0.01% |
16,991
-5,626
| -25% | -$37.8K |
|
5374
Catheter Precision
VTAK
$996K
| $91.2K | ﹤0.01% |
+81
| New | +$67.1K |
|
|
GRNA
5375
DELISTED
GreenLight Biosciences Holdings, PBC Common Stock
GRNA
| $91K | ﹤0.01% |
77,078
+47,996
| +165% | +$78.2K |
|
Similar funds
Goldman Sachs's Q4 2022 Portfolio in Review
As of Q4 2022, Goldman Sachs held 6,669 positions worth $408B, up 3.1% from $396B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Goldman Sachs withdrew a net $13.2B in Q4 2022, closing 721 positions and reducing 2,588 holdings. Its most notable exit was ChemoCentryx, Inc., an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Perfect Corp worth $104M.
- Goldman Sachs's largest Q4 2022 buy was Perfect Corp: 14,518,235 shares worth $104M.
- Goldman Sachs added most to Vanguard Total Bond Market in Q4 2022, an estimated $1.02B increase.
- Goldman Sachs's biggest Q4 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.62B.
- Goldman Sachs fully exited ChemoCentryx, Inc. in Q4 2022, selling an estimated $290M.
- Goldman Sachs's ten largest holdings make up 15% of its $408B portfolio in Q4 2022.
- Goldman Sachs opened 429 new positions and closed 721 in Q4 2022.
- Goldman Sachs's portfolio value rose 3.1% quarter-over-quarter to $408B.
Based on Goldman Sachs's 13F filing for Q4 2022, filed 13 Feb 2023.